Samantha J. Gilman

At The Regulatory Review, Penn Medicine Chief Privacy Officer Lauren Steinfeld C’89 discusses regulatory compliance in the context of data privacy and health care. Steinfeld argues that health care faces new legal requirements, industry standards, and rapidly changing technology, and that each new development requires strategies to manage risk and seize opportunity. In the case of new rules, health care providers must assess—and if necessary, change—existing internal policies and procedures, training, systems, and more to comply. New technologies also must be understood, she argues, because some may introduce new vulnerabilities and others may provide new opportunities for protecting patient data. https://lnkd.in/ekt4ENf3

19

🚨Webinar Alert! HCP Members-Only🚨 Critical Conversation 2: Shifts in CDPAP Webinar | Thursday, September 5, 2024 | 2:00 pm - 3:00 pm Join us for an exclusive session on New York's transition to a Single Fiscal Intermediary (FI) model within the Consumer Directed Personal Assistance Program (CDPAP). What We'll Cover: 1️⃣ Latest updates on the state's implementation of the Single Statewide FI Request for Offers (RFO) and the related legal challenges. 2️⃣ How Personal Assistants Can Be Personal Care Aides Through the Alternative Competency Demonstration (ACD). 3️⃣ Insights into the new FI administrative payment structure and required operational changes. 🗓️ This webinar is designed for independent and agency-affiliated Fiscal Intermediaries and is FREE for HCP members. 👉 Don't miss out—Register now: https://lnkd.in/gTHWf3tt #HCPMembers#HealthcareWebinar#FiscalIntermediaries#CDPAP#NYHealthcare#SingleFIModel#PersonalAssistants#HealthcareUpdates

7

Hopefully today's Federal Trade Commission "interim" report will help Congress get #PBM reform over the finish line this year. Report illustrates how "PBMs wield enormous power over patients’ ability to access and afford their prescription drugs, allowing PBMs to significantly influence what drugs are available and at what price." It also quantifies how "PBMs are highly concentrated and vertically integrated with the nation’s largest health insurers and specialty and retail pharmacies." * PBMs oversee critical decisions about access to and affordability of life-saving medications, without transparency or accountability to the public. * Vertically integrated PBMs appear to have the ability and incentive to prefer their own affiliated businesses, creating conflicts of interest that can disadvantage unaffiliated pharmacies and increase prescription drug costs. * The top three PBMs processed nearly 80% of 6.6 billion prescriptions in 2023 & the top six PBMs processed more than 90%. * Pharmacies affiliated with the three largest PBMs now account for nearly 70% of all specialty drug revenue. https://lnkd.in/e9a-MHMF

15

In 2023, The Pennsylvania Health Care Cost Containment Council (PHC4) dove into developing and releasing valuable reporting and resources, access our 2023 Annual Report now to learn more about the health care insights PHC4's data provides, https://lnkd.in/ewK9RabU

7

For National Immunization Awareness Month, the S.C. Department of Public Health and Prisma Health highlight the significance of vaccines in the play for global health protection. Watch the press conference to hear their discussion about the crucial role that vaccines play in fighting against various diseases and cancers: https://bit.ly/4dLJInG

5

A new Manatt paper describes current #Medicaid policies on #prenatalvaccines and policy strategies to promote access. Despite demonstrated effectiveness, prenatal vaccine uptake remains low, especially among the lower-income pregnant people covered by #Medicaid and #CHIP. These disparities may reflect in part lower reimbursement rates compared to Medicare and commercial insurance. The findings and recommendations in this white paper, authored by Helen Pfister, Julian Polaris and Kelechi Ezealaji, are informed by a recent assessment of relevant policies in all 50 states, plus Washington, D.C. and Puerto Rico. Read the full paper here: https://lnkd.in/e4ts-UnM

7

1 Comment

AHRQ will publish a notice of funding opportunity (NOFO) to create State-based Healthcare Extension Cooperatives that can accelerate the implementation of patient-centered outcome #research (PCOR) evidence into practice. In addition, AHRQ intends to publish two related NOFOs, a National Coordinating Center, and National Evaluation Center to support AHRQ’s Healthcare Extension Service, State-based Solutions to Healthcare Improvement. The purpose of the initiative is to accelerate dissemination and implementation of PCOR evidence and to reduce healthcare disparities. Learn more about this Notice of Intent. https://bit.ly/3Vv9lmk

2

AHRQ will publish a notice of funding opportunity (NOFO) to create State-based Healthcare Extension Cooperatives that can accelerate the implementation of patient-centered outcome #research (PCOR) evidence into practice. In addition, AHRQ intends to publish two related NOFOs, a National Coordinating Center, and National Evaluation Center to support AHRQ’s Healthcare Extension Service, State-based Solutions to Healthcare Improvement. The purpose of the initiative is to accelerate dissemination and implementation of PCOR evidence and to reduce healthcare disparities. Learn more about this Notice of Intent. https://bit.ly/3Vv9lmk

3

AHRQ will publish a notice of funding opportunity (NOFO) to create State-based Healthcare Extension Cooperatives that can accelerate the implementation of patient-centered outcome #research (PCOR) evidence into practice. In addition, AHRQ intends to publish two related NOFOs, a National Coordinating Center, and National Evaluation Center to support AHRQ’s Healthcare Extension Service, State-based Solutions to Healthcare Improvement. The purpose of the initiative is to accelerate dissemination and implementation of PCOR evidence and to reduce healthcare disparities. Learn more about this Notice of Intent. https://bit.ly/3Vv9lmk

2

AHRQ will publish a notice of funding opportunity (NOFO) to create State-based Healthcare Extension Cooperatives that can accelerate the implementation of patient-centered outcome #research (PCOR) evidence into practice. In addition, AHRQ intends to publish two related NOFOs, a National Coordinating Center, and National Evaluation Center to support AHRQ’s Healthcare Extension Service, State-based Solutions to Healthcare Improvement. The purpose of the initiative is to accelerate dissemination and implementation of PCOR evidence and to reduce healthcare disparities. Learn more about this Notice of Intent. https://bit.ly/3Vv9lmk

3

Every #independentpharmacy, every #healthcare professional, & every #patient in America that is fed up with big insurance & their pbm henchmen unethically operating in the murky shadows needs to take advantage of this portal! Let's shine some glaring light on #pbms anticompetitive practices! https://lnkd.in/g-cgYqwC

12

We are thrilled to be partnering with Capital Health (US) Hopewell and Penn Medicine Princeton Medical Center to launch the Raising the Bar for Maternal Health Equity and Excellence initiative based on recommendations from the National Partnership for Women & Families' guide. This two-year initiative aims to improve maternal and child health outcomes, advance birth equity, and enhance the experiences of individuals during childbirth: https://lnkd.in/gVH3ivg5

6

1 Comment

The Harvard Law School Center for Health Law and Policy Innovation and the National Viral Hepatitis Roundtable (NVHR) recently published updates to state report cards reflecting changes to hepatitis C treatment access in Medicaid programs since the organizations’ February 2024 National Snapshot Report. Notably, Arkansas’ removal of substance use restrictions means there are no longer any jurisdictions that require sobriety as a pre-requisite to hepatitis C treatment. “These recent developments are significant steps forward in the fight against hepatitis C,” said Elizabeth Kaplan, Director of Health Care Access at CHLPI. “It is important that states continue to work relentlessly to remove barriers to treatment for people living with HCV, incarcerated individuals, and those living with substance use disorders. The research supports what has long been apparent on the ground—that treatment restrictions create undue barriers to those seeking hepatitis treatment. It is now also clear that a national HCV elimination effort would yield significant cost savings for the government. We have the potential to make remarkable progress towards HCV elimination.”  Read our press release: https://lnkd.in/ewyYXQR9

2

The Harvard Law School Center for Health Law and Policy Innovation and the National Viral Hepatitis Roundtable (NVHR) recently published updates to state report cards reflecting changes to hepatitis C treatment access in Medicaid programs since the organizations’ February 2024 National Snapshot Report. Notably, Arkansas’ removal of substance use restrictions means there are no longer any jurisdictions that require sobriety as a pre-requisite to hepatitis C treatment. “These recent developments are significant steps forward in the fight against hepatitis C,” said Elizabeth Kaplan, Director of Health Care Access at CHLPI. “It is important that states continue to work relentlessly to remove barriers to treatment for people living with HCV, incarcerated individuals, and those living with substance use disorders. The research supports what has long been apparent on the ground—that treatment restrictions create undue barriers to those seeking hepatitis treatment. It is now also clear that a national HCV elimination effort would yield significant cost savings for the government. We have the potential to make remarkable progress towards HCV elimination.”  Read our press release: https://lnkd.in/ewyYXQR9

4

The Harvard Law School Center for Health Law and Policy Innovation and the National Viral Hepatitis Roundtable (NVHR) recently published updates to state report cards reflecting changes to hepatitis C treatment access in Medicaid programs since the organizations’ February 2024 National Snapshot Report. Notably, Arkansas’ removal of substance use restrictions means there are no longer any jurisdictions that require sobriety as a pre-requisite to hepatitis C treatment. “These recent developments are significant steps forward in the fight against hepatitis C,” said Elizabeth Kaplan, Director of Health Care Access at CHLPI. “It is important that states continue to work relentlessly to remove barriers to treatment for people living with HCV, incarcerated individuals, and those living with substance use disorders. The research supports what has long been apparent on the ground—that treatment restrictions create undue barriers to those seeking hepatitis treatment. It is now also clear that a national HCV elimination effort would yield significant cost savings for the government. We have the potential to make remarkable progress towards HCV elimination.”  Read our press release: https://lnkd.in/ewyYXQR9

3

Care managers make a huge impact on our members. Ernie McNutt, Assistant VP of Care Management, discusses the pivotal role of Care Coordination Organizations (CCOs), like ours, support individuals with intellectual and developmental disabilities. Ernie dives into how we offer holistic care, the evolution of care management in New York, and the importance of personalized, strengths-based support. Listen to the IDD Matters Podcast with Craig Escude, MD, FAAFP, FAADM to learn how these efforts are transforming lives and fostering a more inclusive society! #HealthMatters #IDD #EmpoweringIDD #CareDesignNY #NYIDD #NewYorkIDD #CareCoordination #CareManagement

26

3 Comments

Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center has been engaged with a multistakeholder group of colleagues in the Equitable Access to Clinical Trials (EACT) project, an initiative hosted by LUNGevity Foundation to promote sharing best practices and foster collaborative action to advance financial neutrality for patients participating in clinical trials. Patients cite cost as a top reason for declining clinical trial participation. Without comprehensive, explicit regulatory guidance on the acceptability of financial support for trial participants, sponsor and institutional review board (IRB) interpretations of what is fair, compliant, and achievable will continue to vary. New materials for eliminating financial burden for participants in clinical trials that are now are now available on EACT project website. These include a report on best practice considerations for sponsors, a "Participant Needs and Assessment Guide" to aid clinical trial site personnel in determining patients' assistance needs, and a tool for clinical trial staff on "Engaging with Sponsors about Financial Support Programs for Participants." Click here for additional information: https://bit.ly/3wNTJ3Y

2